WASHINGTON, DC — The Drug Enforcement Administration (DEA) says they are easing some of the requirements imposed by the Controlled Substances Act for researchers conducting clinical trials on cannabidiol (CBD), an extract of marijuana that has been used to reduce seizures in children, among other ailments. According to a press release issued Wednesday by the DEA, […]
DEA Eases Some Requirements for Clinical Trials on Cannabidiol | The Daily Chronic
No comments:
Post a Comment